Kidney International Supplements最新文献

{"title":"Global overview of health systems oversight and financing for kidney care","authors":"Aminu K. Bello ,&nbsp;Mona Alrukhaimi ,&nbsp;Gloria E. Ashuntantang ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Mohammed Benghanem Gharbi ,&nbsp;Branko Braam ,&nbsp;John Feehally ,&nbsp;David C. Harris ,&nbsp;Vivekanand Jha ,&nbsp;Kailash Jindal ,&nbsp;David W. Johnson ,&nbsp;Kamyar Kalantar-Zadeh ,&nbsp;Rumeyza Kazancioglu ,&nbsp;Peter G. Kerr ,&nbsp;Meaghan Lunney ,&nbsp;Timothy Olusegun Olanrewaju ,&nbsp;Mohamed A. Osman ,&nbsp;Jeffrey Perl ,&nbsp;Harun Ur Rashid ,&nbsp;Ahmed Rateb ,&nbsp;Adeera Levin","doi":"10.1016/j.kisu.2017.10.008","DOIUrl":"10.1016/j.kisu.2017.10.008","url":null,"abstract":"<div><p>Reliable governance and health financing are critical to the abilities of health systems in different countries to sustainably meet the health needs of their peoples, including those with kidney disease. A comprehensive understanding of existing systems and infrastructure is therefore necessary to globally identify gaps in kidney care and prioritize areas for improvement. This multinational, cross-sectional survey, conducted by the ISN as part of the Global Kidney Health Atlas, examined the oversight, financing, and perceived quality of infrastructure for kidney care across the world. Overall, 125 countries, comprising 93% of the world’s population, responded to the entire survey, with 122 countries responding to questions pertaining to this domain. National oversight of kidney care was most common in high-income countries while individual hospital oversight was most common in low-income countries. Parts of Africa and the Middle East appeared to have no organized oversight system. The proportion of countries in which health care system coverage for people with kidney disease was publicly funded and free varied for AKI (56%), nondialysis chronic kidney disease (40%), dialysis (63%), and kidney transplantation (57%), but was much less common in lower income countries, particularly Africa and Southeast Asia, which relied more heavily on private funding with out-of-pocket expenses for patients. Early detection and management of kidney disease were least likely to be covered by funding models. The perceived quality of health infrastructure supporting AKI and chronic kidney disease care was rated poor to extremely poor in none of the high-income countries but was rated poor to extremely poor in over 40% of low-income countries, particularly Africa. This study demonstrated significant gaps in oversight, funding, and infrastructure supporting health services caring for patients with kidney disease, especially in low- and middle-income countries.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Pages 41-51"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2017.10.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36890417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Building blocks toward sustainable kidney care around the world: results from a multinational survey by the International Society of Nephrology","authors":"Adeera Levin (Executive Director, British Columbia Provincial Renal Agency; Editor-In-Chief, Canadian Journal of Kidney Health and Disease; Past President, International Society of Nephrology (2015–2017))","doi":"10.1016/j.kisu.2017.10.006","DOIUrl":"10.1016/j.kisu.2017.10.006","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Pages 27-29"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2017.10.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36890415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development","authors":"Emily J. See ,&nbsp;Mona Alrukhaimi ,&nbsp;Gloria E. Ashuntantang ,&nbsp;Aminu K. Bello ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Mohammed Benghanem Gharbi ,&nbsp;Branko Braam ,&nbsp;John Feehally ,&nbsp;David C. Harris ,&nbsp;Vivekanand Jha ,&nbsp;Kailash Jindal ,&nbsp;Kamyar Kalantar-Zadeh ,&nbsp;Rumeyza Kazancioglu ,&nbsp;Adeera Levin ,&nbsp;Meaghan Lunney ,&nbsp;Ikechi G. Okpechi ,&nbsp;Timothy Olusegun Olanrewaju ,&nbsp;Mohamed A. Osman ,&nbsp;Jeffrey Perl ,&nbsp;Bilal Qarni ,&nbsp;David W. Johnson","doi":"10.1016/j.kisu.2017.10.011","DOIUrl":"10.1016/j.kisu.2017.10.011","url":null,"abstract":"<div><p>Development and planning of health care services requires robust health information systems to define the burden of disease, inform policy development, and identify opportunities to improve service provision. The global coverage of kidney disease health information systems has not been well reported, despite their potential to enhance care. As part of the Global Kidney Health Atlas, a cross-sectional survey conducted by the International Society of Nephrology, data were collected from 117 United Nations member states on the coverage and scope of kidney disease health information systems and surveillance practices. Dialysis and transplant registries were more common in high-income countries. Few countries reported having nondialysis chronic kidney disease and acute kidney injury registries. Although 62% of countries overall could estimate their prevalence of chronic kidney disease, less than 24% of low-income countries had access to the same data. Almost all countries offered chronic kidney disease testing to patients with diabetes and hypertension, but few to high-risk ethnic groups. Two-thirds of countries were unable to determine their burden of acute kidney injury. Given the substantial heterogeneity in the availability of health information systems, especially in low-income countries and across nondialysis chronic kidney disease and acute kidney injury, a global framework for prioritizing development of these systems in areas of greatest need is warranted.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Pages 74-81"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2017.10.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36891312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project","authors":"Htay Htay ,&nbsp;Mona Alrukhaimi ,&nbsp;Gloria E. Ashuntantang ,&nbsp;Aminu K. Bello ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Mohammed Benghanem Gharbi ,&nbsp;Branko Braam ,&nbsp;John Feehally ,&nbsp;David C. Harris ,&nbsp;Vivekanand Jha ,&nbsp;Kailash Jindal ,&nbsp;Kamyar Kalantar-Zadeh ,&nbsp;Rumeyza Kazancioglu ,&nbsp;Peter G. Kerr ,&nbsp;Adeera Levin ,&nbsp;Meaghan Lunney ,&nbsp;Ikechi G. Okpechi ,&nbsp;Michelle E. Olah ,&nbsp;Timothy Olusegun Olanrewaju ,&nbsp;Mohamed A. Osman ,&nbsp;David W. Johnson","doi":"10.1016/j.kisu.2017.10.010","DOIUrl":"10.1016/j.kisu.2017.10.010","url":null,"abstract":"<div><p>Access to essential medications and health products is critical to effective management of kidney disease. Using data from the ISN Global Kidney Health Atlas multinational cross-sectional survey, global access of patients with kidney disease to essential medications and health products was examined. Overall, 125 countries participated, with 118 countries, composing 91.5% of the world’s population, providing data on this domain. Most countries were unable to access eGFR and albuminuria in their primary care settings. Only one-third of low-income countries (LICs) were able to measure serum creatinine and none were able to access eGFR or quantify proteinuria. The ability to monitor diabetes mellitus through serum glucose and glycated hemoglobin measurements was suboptimal. Pathology services were rarely available in tertiary care in LICs (12%) and lower middle-income countries (45%). While acute and chronic hemodialysis services were available in almost all countries, acute and chronic peritoneal dialysis services were rarely available in LICs (18% and 29%, respectively). Kidney transplantation was available in 79% of countries overall and in 12% of LICs. While over one-half of all countries publicly funded RRT and kidney medications with or without copayment, this was less common in LICs and lower middle-income countries. In conclusion, this study demonstrated significant gaps in services for kidney care and funding that were most apparent in LICs and lower middle-income countries.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Pages 64-73"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2017.10.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36890419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system","authors":"Mohamed A. Osman ,&nbsp;Mona Alrukhaimi ,&nbsp;Gloria E. Ashuntantang ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Mohammed Benghanem Gharbi ,&nbsp;Branko Braam ,&nbsp;Mark Courtney ,&nbsp;John Feehally ,&nbsp;David C. Harris ,&nbsp;Vivekanand Jha ,&nbsp;Kailash Jindal ,&nbsp;David W. Johnson ,&nbsp;Kamyar Kalantar-Zadeh ,&nbsp;Rumeyza Kazancioglu ,&nbsp;Scott Klarenbach ,&nbsp;Adeera Levin ,&nbsp;Meaghan Lunney ,&nbsp;Ikechi G. Okpechi ,&nbsp;Timothy Olusegun Olanrewaju ,&nbsp;Jeffrey Perl ,&nbsp;Aminu K. Bello","doi":"10.1016/j.kisu.2017.10.009","DOIUrl":"10.1016/j.kisu.2017.10.009","url":null,"abstract":"<div><p>The health workforce is the cornerstone of any health care system. An adequately trained and sufficiently staffed workforce is essential to reach universal health coverage. In particular, a nephrology workforce is critical to meet the growing worldwide burden of kidney disease. Despite some attempts, the global nephrology workforce and training capacity remains widely unknown. This multinational cross-sectional survey was part of the Global Kidney Health Atlas project, a new initiative administered by the International Society of Nephrology (ISN). The objective of this study was to address the existing global nephrology workforce and training capacity. The questionnaire was administered online, and all data were analyzed and presented by ISN regions and World Bank country classification. Overall, 125 United Nations member states responded to the entire survey, with 121 countries responding to survey questions pertaining to the nephrology workforce. The global nephrologist density was 8.83 per million population (PMP); high-income countries reported a nephrologist density of 28.52 PMP compared with 0.31 PMP in low-income countries. Similarly, the global nephrologist trainee density was 1.87 PMP; high-income countries reported a 30 times greater nephrology trainee density than low-income countries (6.03 PMP vs. 0.18 PMP). Countries reported a shortage in all care providers in nephrology. A nephrology training program existed in 79% of countries, ranging from 97% in high-income countries to 41% in low-income countries. In countries with a training program, the majority (86%) of programs were 2 to 4 years, and the most common training structure (56%) was following general internal medicine. We found significant variation in the global density of nephrologists and nephrology trainees and shortages in all care providers in nephrology; the gap was more prominent in low-income countries, particularly in African and South Asian ISN regions. These findings point to significant gaps in the current nephrology workforce and opportunities for countries and regions to develop and maintain a sustainable workforce.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Pages 52-63"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2017.10.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36890418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology","authors":"Ikechi G. Okpechi ,&nbsp;Mona Alrukhaimi ,&nbsp;Gloria E. Ashuntantang ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Mohammed Benghanem Gharbi ,&nbsp;Branko Braam ,&nbsp;John Feehally ,&nbsp;David C. Harris ,&nbsp;Vivekanand Jha ,&nbsp;Kailash Jindal ,&nbsp;David W. Johnson ,&nbsp;Kamyar Kalantar-Zadeh ,&nbsp;Rumeyza Kazancioglu ,&nbsp;Adeera Levin ,&nbsp;Meaghan Lunney ,&nbsp;Timothy Olusegun Olanrewaju ,&nbsp;Vlado Perkovic ,&nbsp;Jeffrey Perl ,&nbsp;Harun Ur Rashid ,&nbsp;Eric Rondeau ,&nbsp;Aminu K. Bello","doi":"10.1016/j.kisu.2017.10.012","DOIUrl":"10.1016/j.kisu.2017.10.012","url":null,"abstract":"<div><p>Due to the worldwide rising prevalence of chronic kidney disease (CKD), there is a need to develop strategies through well-designed clinical studies to guide decision making and improve delivery of care to CKD patients. A cross-sectional survey was conducted based on the International Society of Nephrology Global Kidney Health Atlas data. For this study, the survey assessed the capacity of various countries and world regions in participating in and conducting kidney research. Availability of national funding for clinical trials was low (27%, <em>n</em> = 31), with the lowest figures obtained from Africa (7%, <em>n</em> = 2) and South Asia (0%), whereas high-income countries in North America and Europe had the highest participation in clinical trials. Overall, formal training to conduct clinical trials was inadequate for physicians (46%, <em>n</em> = 53) and even lower for nonphysicians, research assistants, and associates in clinical trials (34%, <em>n</em> = 39). There was also diminished availability of workforce and funding to conduct observational cohort studies in nephrology, and participation in highly specialized transplant trials was low in many regions. Overall, the availability of infrastructure (bio-banking and facilities for storage of clinical trial medications) was low, and it was lowest in low-income and lower-middle–income countries. Ethics approval for study conduct was mandatory in 91% (<em>n</em> = 106) of countries and regions, and 62% (<em>n</em> = 66) were reported to have institutional committees. Challenges with obtaining timely approval for a study were reported in 53% (<em>n</em> = 61) of regions but the challenges were similar across these regions. A potential limitation is the possibility of over-reporting or under-reporting due to social desirability bias. This study highlights some of the major challenges for participating in and conducting kidney research and offers suggestions for improving global kidney research.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Pages 82-89"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2017.10.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36891313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Subscription Information","authors":"","doi":"10.1016/S2157-1716(17)30103-X","DOIUrl":"https://doi.org/10.1016/S2157-1716(17)30103-X","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Page A4"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2157-1716(17)30103-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72054762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Title Page","authors":"","doi":"10.1016/S2157-1716(17)30104-1","DOIUrl":"https://doi.org/10.1016/S2157-1716(17)30104-1","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Page A5"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2157-1716(17)30104-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72054763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guidelines, policies, and barriers to kidney care: findings from a global survey","authors":"Meaghan Lunney ,&nbsp;Mona Alrukhaimi ,&nbsp;Gloria E. Ashuntantang ,&nbsp;Aminu K. Bello ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Mohammed Benghanem Gharbi ,&nbsp;Vivekanand Jha ,&nbsp;David W. Johnson ,&nbsp;Kamyar Kalantar-Zadeh ,&nbsp;Rumeyza Kazancioglu ,&nbsp;Michelle E. Olah ,&nbsp;Timothy Olusegun Olanrewaju ,&nbsp;Mohamed A. Osman ,&nbsp;Yasin Parpia ,&nbsp;Jeffrey Perl ,&nbsp;Harun Ur Rashid ,&nbsp;Ahmed Rateb ,&nbsp;Eric Rondeau ,&nbsp;Laura Sola ,&nbsp;Irma Tchokhonelidze ,&nbsp;Adeera Levin","doi":"10.1016/j.kisu.2017.10.007","DOIUrl":"10.1016/j.kisu.2017.10.007","url":null,"abstract":"<div><p>An international survey led by the International Society of Nephrology in 2016 assessed the current capacity of kidney care worldwide. To better understand how governance and leadership guide kidney care, items pertinent to government priority, advocacy, and guidelines, among others, were examined. Of the 116 responding countries, 36% (<em>n</em> = 42) reported CKD as a government health care priority, which was associated with having an advocacy group (χ2 = 11.57; <em>P</em> = 0.001). Nearly one-half (42%; 49 of 116) of countries reported an advocacy group for CKD, compared with only 19% (21 of 112) for AKI. Over one-half (59%; 68 of 116) of countries had a noncommunicable disease strategy. Similarly, 44% (48 of 109), 55% (57 of 104), and 47% (47 of 101) of countries had a strategy for nondialysis CKD, chronic dialysis, and kidney transplantation, respectively. Nearly one-half (49%; 57 of 116) reported a strategy for AKI. Most countries (79%; 92 of 116) had access to CKD guidelines and just over one-half (53%; 61 of 116) reported guidelines for AKI. Awareness and adoption of guidelines were low among nonnephrologist physicians. Identified barriers to kidney care were factors related to patients, such as knowledge and attitude (91%; 100 of 110), physicians (84%; 92 of 110), and geography (74%; 81 of 110). Specific to renal replacement therapy, patients and geography were similarly identified as a barrier in 78% (90 of 116) and 71% (82 of 116) of countries, respectively, with the addition of nephrologists (72%; 83 of 116) and the health care system (73%; 85 of 116). These findings inform how kidney care is currently governed globally. Ensuring that guidelines are feasible and distributed appropriately is important to enhancing their adoption, particularly in primary care. Furthermore, increasing advocacy and government priority, especially for AKI, may increase awareness and strategies to better guide kidney care.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 2","pages":"Pages 30-40"},"PeriodicalIF":5.5,"publicationDate":"2018-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2017.10.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36890416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials","authors":"Natalia A. Rocha ,&nbsp;Peter A. McCullough","doi":"10.1016/j.kisu.2017.10.004","DOIUrl":"10.1016/j.kisu.2017.10.004","url":null,"abstract":"<div><p>The prevalence of type 2 diabetes is catalyzing a pandemic in kidney disease, with ensuing cardiovascular complications. The effort to identify antidiabetic agents capable of promoting benefits that go beyond the bounds of glucose control has produced remarkable outcomes in recent cardiovascular outcomes trials in patients with type 2 diabetes mellitus, many of whom have diabetic kidney disease. Two novel antidiabetic drug classes, sodium–glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), improve cardiovascular outcomes in different ways, with SGLT2is reducing the risk of heart failure and cardiovascular death and GLP-1 RAs being associated with reduced risk of myocardial infarction and cardiovascular death. Further mechanistic studies and additional cardiovascular outcome trials are ongoing and are expected to determine whether these benefits are a result of class effect, as well as to delineate optimum timing for intervention and population target.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"8 1","pages":"Pages 8-17"},"PeriodicalIF":5.5,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2017.10.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36890413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}